Hey guys,
Not sure if you are aware but treatment for Crohn's disease (clarithromycin, clofazimine and rifabutin combined together) is currently in phase 3 clinical trial conducted in US and other countries. Data was very promising from phase 2.
80% of enrolled patients got into remission without any safety concerns. Drug is developed by Israel based biopharma Redhill. Original compound was created by Australian doctor Thomas Borody who actually cured lots of patients. Redhill purchased a patent from him basically. He is also on their advisory board. I cannot attach any links in here since website does not allow me to do so as newly registered.
Google "conquering crohn's disease Judith Lipton" and find the story how back in 2005 lady in Australia was cured from Crohn's by Dr. Borody.
Also go to Redhill BioPharma website and you can find information in there about RHB-104. This is name of the drug they are developing.
In addition they have other indications targeting H. Pyroli infection, IBS-D, pancreatic cancer. Under Investors section on the website they just submitted the latest presentation on April 25th.
Again, I'm sorry I cannot attach links since I need to have at least 10 messages posted before forum admin will allow me to do so.
I think phase 3 clinical study for Crohn's ( also H.Pyroli) should be done by end 2017 with potential early stop by mid 2017 if data is superior showing that at least 60% of patients were treated. After that company will submit application to FDA and if Approved drug will be available in the US and Worldwide. This possibly might happen in late 2018. It takes forever to get through all FDA obstacles unfortunately.
Inbox me if interested and I will send you some links I mentioned above.
- Tom
Not sure if you are aware but treatment for Crohn's disease (clarithromycin, clofazimine and rifabutin combined together) is currently in phase 3 clinical trial conducted in US and other countries. Data was very promising from phase 2.
80% of enrolled patients got into remission without any safety concerns. Drug is developed by Israel based biopharma Redhill. Original compound was created by Australian doctor Thomas Borody who actually cured lots of patients. Redhill purchased a patent from him basically. He is also on their advisory board. I cannot attach any links in here since website does not allow me to do so as newly registered.
Google "conquering crohn's disease Judith Lipton" and find the story how back in 2005 lady in Australia was cured from Crohn's by Dr. Borody.
Also go to Redhill BioPharma website and you can find information in there about RHB-104. This is name of the drug they are developing.
In addition they have other indications targeting H. Pyroli infection, IBS-D, pancreatic cancer. Under Investors section on the website they just submitted the latest presentation on April 25th.
Again, I'm sorry I cannot attach links since I need to have at least 10 messages posted before forum admin will allow me to do so.
I think phase 3 clinical study for Crohn's ( also H.Pyroli) should be done by end 2017 with potential early stop by mid 2017 if data is superior showing that at least 60% of patients were treated. After that company will submit application to FDA and if Approved drug will be available in the US and Worldwide. This possibly might happen in late 2018. It takes forever to get through all FDA obstacles unfortunately.
Inbox me if interested and I will send you some links I mentioned above.
- Tom
Last edited:
